720 related articles for article (PubMed ID: 9625170)
1. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
Rubin Grandis J; Melhem MF; Gooding WE; Day R; Holst VA; Wagener MM; Drenning SD; Tweardy DJ
J Natl Cancer Inst; 1998 Jun; 90(11):824-32. PubMed ID: 9625170
[TBL] [Abstract][Full Text] [Related]
2. Epidermal Growth Factor Receptor Expression in Spindle Cell Carcinomas of the Head and Neck.
Watson RF; Chernock RD; Zhang KH; Michel LS; Adkins DR; El-Mofty SK; Lewis JS
Head Neck Pathol; 2015 Sep; 9(3):360-8. PubMed ID: 25563452
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters.
Hashmi AA; Hussain ZF; Aijaz S; Irfan M; Khan EY; Naz S; Faridi N; Khan A; Edhi MM
World J Surg Oncol; 2018 Jun; 16(1):118. PubMed ID: 29954411
[TBL] [Abstract][Full Text] [Related]
4. Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma.
Rubin Grandis J; Tweardy DJ; Melhem MF
Clin Cancer Res; 1998 Jan; 4(1):13-20. PubMed ID: 9516947
[TBL] [Abstract][Full Text] [Related]
5. Immunoscoring of epidermal growth factor receptor expression in recurrent cases of oral squamous cell carcinoma.
Mehta A; Chowdhary M; Sinha R
J Oral Pathol Med; 2015 Nov; 44(10):818-22. PubMed ID: 25581523
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of p53, c-erbB-2 and epidermal growth factor receptor on head and neck carcinoma.
Parise Junior O; Carvalho LV; Miguel RE; Kowalski LP
Sao Paulo Med J; 2004 Nov; 122(6):264-8. PubMed ID: 15692721
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy.
Wen QH; Miwa T; Yoshizaki T; Nagayama I; Furukawa M; Nishijima H
Laryngoscope; 1996 Jul; 106(7):884-8. PubMed ID: 8667988
[TBL] [Abstract][Full Text] [Related]
8. Prognostic applications of the epidermal growth factor receptor and its ligand, transforming growth factor-alpha.
Wikstrand CJ; Bigner DD
J Natl Cancer Inst; 1998 Jun; 90(11):799-801. PubMed ID: 9625163
[No Abstract] [Full Text] [Related]
9. Prognostic role of regenerating gene-I in patients with stage-IV head and neck squamous cell carcinoma.
Aboshanif M; Kawasaki Y; Omori Y; Suzuki S; Honda K; Motoyama S; Ishikawa K
Diagn Pathol; 2016 Aug; 11(1):79. PubMed ID: 27539087
[TBL] [Abstract][Full Text] [Related]
10. Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression.
Alterio D; Marvaso G; Maffini F; Gandini S; Chiocca S; Ferrari A; Preda L; Rocca MC; Lepanto D; Fodor C; Volpe S; Dicuonzo S; Laudati A; Giugliano G; Ansarin M; Jereczek-Fossa BA
Med Oncol; 2017 Jun; 34(6):107. PubMed ID: 28452036
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes.
Seethala RR; Gooding WE; Handler PN; Collins B; Zhang Q; Siegfried JM; Grandis JR
Clin Cancer Res; 2008 Mar; 14(5):1303-9. PubMed ID: 18316548
[TBL] [Abstract][Full Text] [Related]
12. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.
Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T
J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611
[TBL] [Abstract][Full Text] [Related]
13. p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma.
Shin DM; Lee JS; Lippman SM; Lee JJ; Tu ZN; Choi G; Heyne K; Shin HJ; Ro JY; Goepfert H; Hong WK; Hittelman WN
J Natl Cancer Inst; 1996 Apr; 88(8):519-29. PubMed ID: 8606380
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871
[TBL] [Abstract][Full Text] [Related]
15. Interaction of transforming growth factor-alpha and epidermal growth factor receptor in breast carcinoma. An immunohistologic study.
Castellani R; Visscher DW; Wykes S; Sarkar FH; Crissman JD
Cancer; 1994 Jan; 73(2):344-9. PubMed ID: 8293398
[TBL] [Abstract][Full Text] [Related]
16. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
[TBL] [Abstract][Full Text] [Related]
17. Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival.
Reinartz JJ; George E; Lindgren BR; Niehans GA
Hum Pathol; 1994 Oct; 25(10):1075-83. PubMed ID: 7927313
[TBL] [Abstract][Full Text] [Related]
18. p16 expression in carcinoma of unknown primary: diagnostic indicator and prognostic marker.
Vent J; Haidle B; Wedemeyer I; Huebbers C; Siefer O; Semrau R; Preuss SF; Klussmann J
Head Neck; 2013 Nov; 35(11):1521-6. PubMed ID: 23345170
[TBL] [Abstract][Full Text] [Related]
19. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
20. Podoplanin expression in cutaneous head and neck squamous cell carcinoma--prognostic value and clinicopathologic implications.
Kreppel M; Krakowezki A; Kreppel B; Drebber U; Wedemeyer I; Mauch C; Zöller JE; Scheer M
J Surg Oncol; 2013 Mar; 107(4):376-83. PubMed ID: 22886751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]